Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States. Goshua G, Calhoun C, Ito S, James LP, et al. Ann Intern Med 2023;176:779-787.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goshua G, Calhoun C, Ito S, James LP, et al. Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United States. Ann Intern Med 2023;176:779-787.
PMID: 37247420